Error loading player: No playable sources found

Player size: small large

[Harnessing the Microbiome] Clinical Trials to Optimize Microbiome‑Mediated Disease Resistance

Date

January 20, 2021

Co-Chairs

Eric G. Pamer, MD

University of Chicago

Matthew Henn, PhD

Seres Therapeutics

Tracks

Clinical Trials to Optimize Microbiome‑Mediated Disease Resistance

Related Products

Thumbnail for Microbiome Therapeutics to Treat Bacterial Infections and Inflammatory Disease

Microbiome Therapeutics to Treat Bacterial Infections and Inflammatory Disease

Thumbnail for Synthetic Glycans to Optimize Microbiome Composition and Function

Synthetic Glycans to Optimize Microbiome Composition and Function

Thumbnail for [Joint Session] Career Roundtable

[Joint Session] Career Roundtable

Thumbnail for Short Talk: Development of a Synthetic Biotic for the Treatment of Enteric Hyperoxaluria

Short Talk: Development of a Synthetic Biotic for the Treatment of Enteric Hyperoxaluria

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.